BPC-157 in Laboratory Research: Overview and Handling Notes
Background on Body Protection Compound-157, common vial sizes, and practical reconstitution planning for in vitro studies.
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It appears frequently in preclinical literature exploring tissue repair models, angiogenesis, and inflammatory pathways — always in controlled laboratory settings, not as an approved therapeutic.
Research use only
BPC-157 supplied by Peptides EU is sold strictly for in vitro and laboratory research. It is not intended for human consumption, injection outside approved research protocols, or veterinary use.
Typical research vial formats
BPC-157 is commonly supplied lyophilised at 5 mg per vial, though other sizes exist. For planning, reconstituting 5 mg with 2 mL bacteriostatic water yields 2.5 mg/mL — a concentration that makes small sample volumes easy to measure on U-100 syringes for in vitro dosing calculations.
Handling considerations
- Store lyophilised material cold and protected from light until use.
- Reconstitute with bacteriostatic water unless your SOP specifies otherwise.
- Use the batch COA to confirm identity and purity before critical experiments.
- Document batch numbers — BPC-157 activity can vary between lots in sensitive assays.
EU supply advantage
European laboratories ordering BPC-157 from Peptides EU benefit from intra-EU shipping: no customs clearance delays and no import VAT collected at delivery. Materials arrive with tracked, discreet packaging suitable for research facilities.
Related resources
All content is for in vitro laboratory research context only. Not medical advice.